Davita INC 8-K filings

DaVita Inc. announced a $500 million incremental term loan under its senior secured term loan B facility, maturing in May 2031, to repay its revolving loan facility and for general corporate purposes.

DaVita Inc. announced its first quarter 2026 financial and operating results, reporting consolidated revenues of $3.416 billion and diluted earnings per share of $2.87.

DaVita Inc. announced strong financial and operating results for the fourth quarter and full year ended December 31, 2025, meeting financial targets despite a challenging environment.

DaVita Inc. has entered into an Eighth Amendment to its Credit Agreement, securing new five-year term and revolving credit facilities totaling $3.5 billion to refinance existing debt and extend maturities to November 2030.

DaVita Inc. reported third-quarter 2025 financial results in line with expectations, maintaining full-year guidance and increasing its share repurchase authorization.

DaVita Inc.'s Board of Directors approved an additional $2 billion for its share repurchase program, signaling confidence and commitment to shareholder returns.

DaVita Inc. announced solid financial and operating results for the second quarter of 2025, despite incurring charges related to a cybersecurity incident and a decline in normalized non-acquired treatment growth.

DaVita Inc. has successfully repriced its existing senior secured term loan B facility, reducing its interest margin, and secured an additional $250 million in new term loans to repay a portion of its outstanding senior secured term A loans.

DaVita Inc. announced the successful re-election of all nine director nominees, the ratification of KPMG LLP as its independent auditor, and the advisory approval of named executive officer compensation at its virtual 2025 Annual Meeting of Stockholders.

DaVita Inc. has successfully completed a private offering of $1.0 billion in 6.750% Senior Notes due 2033, with net proceeds primarily allocated to repaying outstanding revolving credit facility borrowings and for general corporate purposes.

DaVita Inc. has increased the size of its private offering of senior notes due 2033 from $750 million to $1 billion and priced them at face value with a 6.750% coupon.

DaVita Inc. has announced a private offering of $750 million in senior notes due in 2033 to repay debt and for general corporate purposes.

DaVita Inc. reports solid Q1 2025 financial results, highlighting revenue of $3.224 billion and diluted earnings per share of $2.00, driven by the stability of its operating model.

DaVita Inc. reports a ransomware incident impacting its network and operations, with ongoing investigation to determine the full extent of the disruption.

DaVita Inc. reports its fourth quarter and full year 2024 financial results, highlighting revenue, earnings, and share repurchase activity.

DaVita Inc. announced its third quarter 2024 financial results, highlighting revenue of $3.264 billion and adjusted diluted earnings per share of $2.59, while navigating strategic center closures and debt refinancing.

DaVita Inc. has announced the appointment of David P. Maughan as Chief Operating Officer, Kidney Care, effective September 15, 2024, replacing Michael D. Staffieri.

DaVita Inc.'s board of directors has adopted amended and restated bylaws and approved an additional $2 billion for its share repurchase program.

DaVita Inc. has successfully raised approximately $2.1 billion through a private offering of senior notes and a new term loan facility, using the proceeds to refinance existing debt and for general corporate purposes.

DaVita Inc. has announced the pricing of a $1.0 billion private offering of senior notes due in 2032, with the proceeds intended to repay existing debt and for general corporate purposes.

DaVita Inc. is launching a private offering of $1 billion in senior notes due 2032 and plans to secure a $1 billion term loan to refinance existing debt and for general corporate purposes.

DaVita Inc. announced positive financial results for the second quarter of 2024, with consolidated revenues of $3.187 billion and diluted earnings per share of $2.50.

DaVita Inc. successfully held its 2024 Annual Meeting of Stockholders, electing all director nominees and ratifying the appointment of KPMG LLP as its independent auditor.

DaVita Inc. has successfully amended its credit agreement, extending the maturity of a significant portion of its term loan B facility to May 2031.

DaVita Inc. announced its first quarter 2024 financial results, showing revenue growth but facing challenges from a cyberattack and increased costs.

DaVita Inc. has entered into a share repurchase agreement with Berkshire Hathaway to ensure Berkshire's ownership remains at or below 45% of outstanding shares.

DaVita Inc. has increased its board size and appointed Dennis W. Pullin as a new director, effective April 10, 2024.

DaVita Inc. announced its fourth quarter and full year 2023 financial results, highlighting the company's resilience and strategic investments despite external challenges.